Peresolimab in RA – new name, new pathway, new opportunity? - With Dr. Jay Tuttle
Listen now
Description
Join Philipp Bosch and Pierre-Antoine Juge as they discuss hot topics in rheumatology with special guests.
This week an interview with Dr. Jay Tuttle.
This PD-1 inhibitor was investigated by Dr. Tuttle and his team in a phase 2a RCT published in the NEJM. Dr. Tuttle also share about his career in the industry and how he is now responsible for developing clinical trials!
Editorial Team: Dr Renske Meijer, Dr Bayram Farisogullari, Dr Olivier Fakih, Dr Mrinalini Dey.
More Episodes
Learn more about the use of imaging in the diagnosis and follow-up of patients with gout, CPPD and BCPD.
Join Stefan as he interviews Dr. Georgios Filippou about the 2023 EULAR recommendations for imaging in crystalinduced arthropathies.
Editorial Team: Dr Bayram Farisogullari, Dr Renske...
Published 05/03/24
Published 05/03/24
Join Stefan and Pierre as they interview Dr Manouk de Hooge to discuss her publication on the progression of axPsA, as well as her career within EULAR and EMEUNET.
Editorial Team: Dr Bayram Farisogullari, Dr Renske Meijer, Dr Olivier Fakih, Dr Mrinalini Dey
Published 03/22/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
